Mandangan, Maybel .

HRN: 25-18-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2024
CEFUROXIME 500MG (TAB)
06/14/2024
06/20/2024
PO
1 Tab
BID X 7 Days
S/p NSVD, Thinly MSAF, RMLE With Episioraphy
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: